Aratana Therapeutics Inc (NASDAQ:PETX)

16.25
Delayed Data
As of Mar 27
 -0.22 / -1.34%
Today’s Change
9.20
Today|||52-Week Range
20.63
-8.81%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close16.47
Today’s open16.45
Day’s range16.12 - 16.85
Volume144,445
Average volume (3 months)243,587
Market cap$567.3M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-26.28%
Earnings growth (next 5 years)+8.28%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.03+0.54%
VSARVersartis Inc-0.64-3.21%
SRPTSarepta Therapeutics...+0.50+3.83%
ENTAEnanta Pharmaceutica...-0.43-1.35%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer &
Treasurer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account